Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPIX has been rife with pump 'n' dump, short 'n' distort, and poop 'n' scoop over the years.
I continually get sucked into buying more every time I see someone post a $100+ price target.
Go IPIX!
We don't at this time. Moderate-severe COVID = hospitalization so IV isn't so bad in that setting.
That's not to mention all the other viral indications that are potentially on the table.
Influenza = 500,000 hospitalizations per year in the US alone. x$1000 per treatment you have durable $500M/year indication using an IV.
Then go to Pneumonia, MRSA, Cdiff, etc.
Plenty of addressable market for an IV antibiotic/viral.
Go IPIX!
Im quite excited about that news. One AI ranking could be a fluke. Two is a bit more solid.
All comes down to dosage levels. Is it enough? All signs point to an optimistic maybe.
Go IPIX!
No need to fear. Any time before Thanksgiving is within my forecast. No need to worry before then.
Go IPIX!
Ok, let's go with your premise for fun.
Don't you think it is interesting that two separate AI models found Briladin to be a top 3% candidate and a #1 candidate for killing COVID?
More data points means less chance of a fluke.
Go IPIX!
WOoooooooo!
That is impressive to see another AI team find Brilacidin to be extremely effective....#1 in this case.
The ground is packed with tinder. We just need the spark to set it all off. TLD should do it. Eventually we're going to hit news channels.
Go IPIX!
No need to take any explicit action like that. Just giving IPIX no development money has hobbled our rate of development and funneled 10's of billions into the pockets of Gilead, Regeneron, Pfizer, and Moderna.
All they need to do is sit back and watch us struggle to fund our trials as they have for years.
Go IPIX!
Give it time. Biotech is a 10-year investment. 2012-2022. The time is upon us for new heights and the spring time of our youth here at IPIX.
Go IPIX!
IPIX is a complete unknown. That's part of the value proposition.
Go IPIX!
Oh, I wasn't talking about foul play on the part of Leo or the company. Leo runs virtuous operation and he will earn a Nobel Prize for his altruistic efforts. That is why he has my tireless loyalty as a shareholder...I may even buy more this week.
I was talking about foul play on the part of nefarious detractors who wish to see IPIX be delayed in bringing Brilacidin to market.
GO IPIX!
This is part of the reason I want a BP partner with a vested interest in advancing these drugs. Everything is in house or with a trusted resource. Putting this stuff out to the lowest bidder as a no name company is just asking for trouble.
IPIX needs a pocket to hold in this cut throat industry. Better to be a tenderly loved B than a beaten and loved B.
Go IPIX!
Existing COVID therapeutics are doing well over $1B per month in sales.
If nefarious entities bribe a small data shop to slow walk results by a few weeks that is a tremendous ROI. $100K in a paper bag to a few data analysts could keep Brilacidin off the market and extra month or two. That's billions saved by the nefarious.
I have no doubt foul play is involved.
Go IPIX!
Yeah, I'm waiting for the days when I look back and regret not buying more.
Go IPIX!
It's all working as intended Daubers.
Go IPIX!
Fellow Shareholders,
I write to you this eve on the precipice of a hopefully successful B-COVID top line data. We have waited many years...some of us closing in on a decade for the success we will soon taste in IPIX.
To everyone who has put their hard-earned money where their mouth is...thank you. IPIX could not have made it this far without everyone sticking together and helping to finance operations and trials all these years. We have finally made it and this company is going to transform medicine as we know it and bring us all financial success we could have only dreamed of before.
This will truly be a December to remember starting with this week. Let's put an end to COVID-19 and dozens of other maladies over the coming months and years.
God Bless and GO IPIX!
Very big difference.
There, of course, comes a point when over a number of years that the number of missed anticipated timelines begins to add up.
For example, I can't get any of my personal friends to invest any more into IPIX. I have told them six times that "this trial should be the one that launches us" and six times I have cost them money. Now, here we sit on the eve of results of the trial that actually WILL launch us into the stratosphere and there are no takers.
Wish I could get them to bite but they are currently content with their $0.70s, and $1.60s, and $3.10s (oof). Hopefully they'll all be green by lunchtime tomorrow.
Go IPIX!
If this happens:
Let's hope the bar is very high for that $40M.
I hope he is awarded it tomorrow at 11am.
Go IPIX!
We have rarely held a cash balance that high. Every trial we have run has cost $10M or less.
Plenty of money for additional B trials such as B-UC phase 2. Possibly even enough phase 3 OM given the simply delivery method.
Go IPIX!
Untrue. We have over $10M in the bank per the latest 10Q. If the COVID trial fails miserably IPIX will still be in a much stronger position than it was 18 months ago from a financial perspective.
IPIX has more money stashed away to carry on than it has in many years. Leo has been very wise to raise such a sum as a contingency for the COVID trial.
Go IPIX!
This week is definitely the sweet spot for the most recent anticipated guidance by the company.
It's possible it will be later as it is only anticipated guidance but I think it is reasonable to expect a release or an update this week.
Go IPIX!
It's going to be one for the record books for sure. We just have to have faith in Leo and Brilacidin.
Go IPIX!
It will be.
IPIX will be financially reinvigorated very shortly. It will be firing on all cylinders advancing Brilacidin and Kevetrin across numerous indications over the next decade.
Go IPIX!
Half of those are pretty small markets in very poor nations right?
HIV
Herps
Rotavirus
Influenza
The others are pretty small.
Influenza alone....500,000 hospitalizations/year in the US. $1000/treatment is $500M/year on a durable indication. Probably worth a few billion on the market cap by itself in the US easy.
If they all work? Golly. $10s of billions of revenue per year. Stock price well over $100. Maybe the largest pharma on Earth.
The future is insanely bright for IPIX if any of these indications work out though.
Go IPIX!
Fun timeline.
Oct 2, 2020 - FDA grants pre-IND meeting
Dec 21, 2020 - FDA grants IND approval
Feb 1, 2021 - Trial began
Jun 3, 2021 - Enrollment complete
Aug 12, 2021 - Last patient followup
Oct 23, 2021 - Still no data
It has taken over a year to get this trial going to dose 60 patients and still nothing. If Brilacidin works...what a failure of red tape.
Unbelievable. How many people died the last four months during followups and data collection on 120 patients?
People don't like my signature...but it may be a bit optimistic.
Go IPIX!
Would be nice.
Monday at 11am would be nicer. I want to see at least one person on GoFundMe because they were holding IPIX short at the wrong time mid day.
Go IPIX!
Just 2% huh? I hope its more than that. Going to be tough to show a 2% margin with 60 patients in the B arm.
Go IPIX!
Why else? Cellceutix was a way cooler name. I hope they reclaim it when they uplist to NASDAQ.
Go CTIX!
Valid points and good info.
Also, we're not even late on our anticipated timeframe until Monday 11/1.
Go IPIX!
Well, we did change the CUSIP and the stock name (CTIX to IPIX) in order to reconcile and naked shares back in 2017 amid a flurry of supposed short conspiracies.
There didnt appear to be any massive covering then. So that would be a strike against the naked short theory...at least at that point in time.
Go IPIX!
I'm not "highly skeptical of trial success". I view it as a coin toss with a lopsided payout favoring longs as I always have.
High risk, extreme reward.
I'm hoping for news Monday but if I had to wager...I think its going to be in November.
Go IPIX!
Billy,
Can she provide any more detail on what she saw. I'm talking the transits themselves and what they indicate.
Like "Mars transited the horoscope in way X, this makes me believe results will come on day Y".
I don't really know anything about it. Not sure I put a whole lot of stock into it but I am curious about some specific examples.
If not, no worries. Thanks.
Go IPIX!
The preclinical mice cleared magnificently but it obviously did not translate.
You and I are dependent on this pulling through for our retirements. That doesn't mean we should put others at risk stating this is not high risk.
Should B-COVID fail I wouldn't want to see someone else get crushed holding too much in yet another gamble like we have been over the years. Make sure you have enough to partake in the winnings but please don't over allocate like I have.
Go IPIX!
The point stands. GMU RBL does glorious work. They didn't say anything about whether the dosage we went with in the clinical trial will work or not.
We should be getting results within the next month or so and they will speak for themselves. This is a high risk, extreme reward play right now.
My money is on Brilacidin.
Go IPIX!
We'll lose a lot. But the upside is much higher than the downside.
Get a chunk but dont bet the farm.
Go IPIX!